{Reference Type}: Randomized Controlled Trial
{Title}: Quail egg homogenate with zinc as adjunctive therapy in seasonal allergic rhinitis: a randomised, controlled trial.
{Author}: Andaloro C;Saibene AM;La Mantia I;
{Journal}: J Laryngol Otol
{Volume}: 137
{Issue}: 4
{Year}: Apr 2023
{Factor}: 2.187
{DOI}: 10.1017/S0022215122001219
{Abstract}: <B>OBJECTIVE: </B>Because most available treatments for managing seasonal allergic rhinitis show some side effects without reducing recurrence, natural anti-allergic products could represent an interesting treatment addition. This study aimed to analyse the efficacy and tolerance of quail egg as adjunctive therapy in seasonal allergic rhinitis.<BR><B>METHODS: </B>In a Consolidated Standards of Reporting Trials compliant framework, patients with seasonal allergic rhinitis were prospectively randomised to receive mometasone nasal spray for four weeks or the same topical corticosteroid therapy plus commercially available oral quail egg and zinc tablets.<BR><B>RESULTS: </B>Forty patients were enrolled. The mometasone + quail egg and zinc tablets group showed a greater reduction in nasal itching, sneezing and total nasal symptom scores than the mometasone nasal spray only group. A higher proportion of participants in the mometasone + quail egg and zinc tablets group had good rhinitis control than in the mometasone nasal spray only group, with no need for rescue medications.<BR><B>CONCLUSIONS: </B>Despite the need for a further larger study, quail egg preliminarily appears to be an effective adjunct to topical steroid therapy in seasonal allergic rhinitis.